These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1357502)

  • 21. Local intravenous thrombolysis with recombinant tissue plasminogen activator for salvage of forearm replantation.
    Hashim HA; Atiyeh BS; Hamdan AM; Musharrafieh RS
    J Reconstr Microsurg; 1996 Nov; 12(8):543-6. PubMed ID: 8951123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis with an Escherichia coli-produced recombinant plasminogen activator (BM 06.022) in the rabbit model of jugular vein thrombosis.
    Martin U; Fischer S; Kohnert U; Opitz U; Rudolph R; Sponer G; Stern A; Strein K
    Thromb Haemost; 1991 May; 65(5):560-4. PubMed ID: 1908140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolysis failure: a role for plasminogen activator inhibitor type 1 (PAI-1).
    Nicholls SC; Chandler WL; Hoffer EK
    Br J Haematol; 2001 May; 113(2):559-60. PubMed ID: 11380434
    [No Abstract]   [Full Text] [Related]  

  • 25. Intraarterial subclavian artery thrombolysis in a neonate.
    Neff KW; Dinter D; Schaible T; Lehmann KJ; Düber C
    AJR Am J Roentgenol; 2001 Aug; 177(2):446-8. PubMed ID: 11461880
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal renal vein thrombosis: role of anticoagulation and thrombolysis--an institutional review.
    Bidadi B; Nageswara Rao AA; Kaur D; Khan SP; Rodriguez V
    Pediatr Hematol Oncol; 2016 Feb; 33(1):59-66. PubMed ID: 26918622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator.
    Kennedy LA; Drummond WH; Knight ME; Millsaps MM; Williams JL
    J Pediatr; 1990 May; 116(5):798-801. PubMed ID: 2109793
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of captopril on plasma endothelin-1 during thrombolysis: preliminary findings.
    Di Pasquale P; Paterna S; Parrinello G; Bucca V; Caracausi R; Pipitone F; Licata G
    Cardiovasc Drugs Ther; 1995 Apr; 9(2):359-60. PubMed ID: 7662604
    [No Abstract]   [Full Text] [Related]  

  • 29. Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.
    Rodenhuis S; van't Hek LG; Vlasveld LT; Kröger R; Dubbelman R; van Tol RG
    Thorax; 1993 May; 48(5):558-9. PubMed ID: 8322245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New strategies and perspectives in thrombolytic therapy].
    Bode C; Kübler W
    Internist (Berl); 1992 Apr; 33(4):258-64. PubMed ID: 1612850
    [No Abstract]   [Full Text] [Related]  

  • 31. [Plasminogen activators and thrombolytic therapy].
    Taran LD
    Biomed Khim; 2005; 51(3):248-62. PubMed ID: 16104388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolysis with reteplase for recurrent mechanical heartvalve thrombosis.
    Akhtar N; Khan YJ; Ahmed W
    J Pak Med Assoc; 2011 Feb; 61(2):189-92. PubMed ID: 21375177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra-arterial thrombolysis (reteplase) and ReoPro for subacute thrombosis of the distal aorta accomplished by radial arterial access: the radial-kissing-thrombolytic technique.
    de La Serna FA; Tolleson TR; Crowley JJ; Stack RS; Zidar JP
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):264-8. PubMed ID: 11387618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful lysis of an obstructive aortic and renal artery thrombus in a neonate on extracorporeal membrane oxygenation.
    Gunnarsson B; Heard CM; Martin DJ; Brecher ML; Steinhorn RH
    J Perinatol; 2000 Dec; 20(8 Pt 1):555-7. PubMed ID: 11190598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator in peripheral arterial thrombolysis.
    Dawson K; Stansby G; Novell R; Hehir D
    Br J Surg; 1990 Aug; 77(8):954-5. PubMed ID: 2118409
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog.
    Clare AC; Kraje BJ
    J Am Vet Med Assoc; 1998 Feb; 212(4):539-43. PubMed ID: 9491162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial occlusions.
    Dawson KJ; Hamilton G
    Radiology; 1991 Jan; 178(1):283-4. PubMed ID: 1898537
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of recombinant tissue-type plasminogen activator in a newborn with an intracardiac thrombus developed during extracorporeal membrane oxygenation.
    Garcia A; Gander JW; Gross ER; Reichstein A; Sheth SS; Stolar CJ; Middlesworth W
    J Pediatr Surg; 2011 Oct; 46(10):2021-4. PubMed ID: 22008344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of pulse-sprayed recombinant tissue plasminogen activator for deep venous thrombosis.
    Horne MK; Chang R
    Thromb Res; 2003; 111(1-2):111-4. PubMed ID: 14644088
    [No Abstract]   [Full Text] [Related]  

  • 40. Thrombolysis of prosthetic tricuspid valve thrombosis with human recombinant tissue plasminogen activator in an adolescent.
    Bolz D; Kühne T; Jivraj R; Hammer J
    Pediatr Cardiol; 2000; 21(4):397-400. PubMed ID: 10865025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.